Eulerpool Terminal
The edge that pays for itself.
Current Xvivo Perfusion forecasts and price targets in October 2026
Ø Analyst Price Targets
312.12 SEK
+48.49 %
Median
306.00 SEK
+45.58 %
Max
404.25 SEK
Min
247.45 SEK
Last Price
210.20 SEK
Buy
12
Hold
1
Sell
0
The average target price for Xvivo Perfusion is 312.12 SEK. (+48.49 % above the current price)
The median price target of Xvivo Perfusion is 306.00 SEK.
Stock analysts from many renowned investment banks are closely examining the Xvivo Perfusion stock. They conclude their professional Xvivo Perfusion stock analyses with a clear recommendation for the Xvivo Perfusion stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-04-01 | 12 | 1 | 0 | — |
| 2026-03-01 | 12 | 1 | 0 | 312.12 SEK |
| 2026-02-01 | 12 | 1 | 0 | 312.12 SEK |
| 2026-01-01 | 10 | 2 | 0 | 371.89 SEK |
| 2025-12-01 | 11 | 2 | 0 | 371.89 SEK |
| 2025-11-01 | 11 | 2 | 0 | 371.89 SEK |
Xvivo Perfusion Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Xvivo Perfusion in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 991.00 M SEK | 107.00 M SEK | 3.39 SEK |
| 2027e | 1.24 B SEK | 183.00 M SEK | 5.80 SEK |
| 2028e | 1.59 B SEK | 293.00 M SEK | 9.28 SEK |